The Recovery Delivers, but Garden Inventory and a Fuller Price Narrow the Upside

Results vs. Consensus

Year-over-year comparison

Sequential comparison

Revenue assessment: Organic growth of 6.6% is materially stronger than Q2’s 1.5%, with only $7.5M of currency assistance this quarter. H&G contributed $36.0M of the $53.7M reported sales increase, roughly two-thirds. That concentration matters: the strongest business drove a real seasonal recovery, but its retailer replenishment pattern makes the quarter an unreliable run rate for Q4. Pet care’s positive growth after the expected $9M timing headwind is the more useful test of sustained commercial progress.

Margin assessment: Excluding refunds, gross profit rose $45.7M to $309.8M as volume, pricing, mix and productivity more than offset tariff costs. The EBITDA gain was less than half that gross-profit improvement, consistent with stepped-up investment and higher corporate expense absorbing part of the benefit. This supports a modest increase in recurring earnings expectations; it does not support capitalizing the full 49.2% reported gross margin.

EPS assessment: A $104.0M noncash HPC impairment and $28.8M of income tax expense produced a GAAP continuing loss even as the businesses improved. The adjusted EPS reconciliation removes the impairment but retains the refund benefit. Removing the disclosed $1.90 refund contribution leaves $0.89, below both last year and the pre-print EPS range. The quarter included $19.2M of tax on internal asset transfers and $58.1M for an HPC deferred tax liability, partly offset by a $47.1M capital-loss tax benefit, plus $15.0M of return-to-provision expense. These transaction-related items make $0.89 a poor measure of a normal quarter’s earning power. Management’s FY26 adjusted tax assumption increased to 32.8%, incorporating the HPC transaction. The quarter therefore fails to repeat May’s clean EPS conversion, although the operating EBITDA evidence remains positive. A lower share count helped rather than caused that underlying EPS decline.

Segment Performance

Segment EBITDA and margins below exclude the one-time tariff refunds in Q3 FY26; the comparison year had no corresponding refunds.

Global Pet Care: the growth test holds after the pull-forward unwind

Pet care posted its third consecutive quarter of positive organic growth. North American sales rose high single digits, with key chews, stain-and-odor and grooming brands maintaining or gaining share. Companion animal grew mid single digits, while aquatics declined mid single digits. The $3M e-commerce shipment reversal and $6M EMEA pre-buy reversal were the headwinds flagged in May. Q3 also benefited from an easier comparison: last year’s temporary stop in shipments during retail pricing negotiations deferred orders into Q4. Those opposing timing effects limit what the slowdown from 7.6% organic growth to 2.9% says about durable demand. Share gains and positive, albeit modest, volume growth offer the stronger evidence that commercial progress persisted.

"We do have volume growth now, not a lot, but we have volume growth in our GPC business."
— Faisal Qadir, CFO

Pricing, mix and cost actions lifted underlying EBITDA by $7.9M, even with reinvestment elevated. Good Boy’s distribution gains in continental Europe and leadership in the U.K. provide an identifiable growth route beyond a recovery in category demand. North American price-pack changes are now implemented, giving retailers a clearer good-better-best assortment.

Assessment: The quarter supports the pet pillar through share gains, modest volume growth and margin improvement. Reported growth survived the known timing reversal with help from the easier prior-year shipment comparison. We retain a positive underlying sales outlook, but allow for a reported Q4 decline as last year’s deferred shipments and Eukanuba launch orders create a harder comparison. Share and consumption trends, rather than that expected single-quarter decline alone, will determine whether the thesis weakens.

Home & Garden: a successful peak season creates a harder exit

Record sales of $225.2M fulfilled the prior peak-season test. Pest controls and herbicides grew double digits, with Spectracide, Hot Shot and Repel outperforming their markets. Last year’s trap launches gained wider distribution, and off-shelf promotional placements increased reach. Underlying EBITDA rose $9.8M to $48.4M as higher volume and productivity outweighed trade spending and inflation.

"The unfavorable weather conditions experienced in late June continued into July with more widespread and persistent heat impacting much of the country. These conditions have also left certain retailers carrying elevated inventory levels, which we expect will temper replenishment orders and weigh on fourth quarter results."
— Faisal Qadir, CFO

The inventory problem developed after retailers ordered against a strong April. Softer May and June consumption, followed by continued weakness in July, left the channel carrying more product than planned. That reverses the favorable low-inventory setup emphasized in May. It does not erase the innovation gains, but it separates this quarter’s shipments from the next quarter’s demand for replenishment.

Assessment: H&G delivered the seasonal growth the Outperform required, but the exit is weaker than the record headline suggests. Our Q4 sales assumption of about $129M is below last year’s $139.2M, allowing the channel to normalize. The growth pillar remains on track for FY26; the new inventory risk limits how much of this record quarter should carry into FY27 expectations.

Home & Personal Care: better profitability, incomplete demand repair

HPC returned to reported and organic growth, with personal care up mid teens and appliances down mid single digits. Latin American launches and improving Remington performance offer evidence of better execution. Yet North American sales still declined mid single digits, and EMEA sales benefited from a one-time reduction in trade spending that was offset in operating expenses. The small positive organic print consequently overstates the breadth of the demand recovery.

"Our focus remains on improving profitability with plans in place to deliver full year adjusted EBITDA growth versus prior year despite a projected decline in net sales for the full year."
— Faisal Qadir, CFO

Assessment: Underlying EBITDA more than doubled from $7.0M to $14.4M, supporting the prior manage-for-profit case. A 5.4% margin still leaves HPC well behind pet and garden, and the revenue classification benefit is not a fresh source of cash earnings. We give the Oaktree structure credit for funding strategic choices, while requiring further volume and commercial progress before assigning a higher-quality consumer multiple to HPC.

Key KPIs

Key Topics & Management Commentary

Overall Management Tone: Management was confident that the operating recovery had taken hold, but more specific about a difficult year-end than in May. The optimism was supported by margin progress; the reluctance to extrapolate garden replenishment or offer a FY27 framework was also justified by the disclosures.

1. Refund proceeds restore investment capacity

The tariff-refund option identified last quarter has become a recognized asset and a growing cash receipt. Only about $3M of refund cash was included through June, although management said approximately half had arrived by the call and expected most within the fiscal year. That leaves a near-term liquidity benefit without another comparable earnings benefit: the refunds were already booked in Q3.

"So, look, we want to rehire people. We want to invest in commercial activity. So that's where this is going. But this is just recouping some of the money that we lost last year."
— David Maura, Chairman & CEO

Assessment: Refund collection reduces funding pressure and can support the next stage of growth. The decision to rebuild commercial capacity means the proceeds are not an automatic special distribution or permanent margin uplift. Our valuation credits net cash improvement once, after allowing for reinvestment and ordinary capital returns.

2. Commercial investment changes the operating-leverage bargain

SG&A rose $25.5M, or 11.3%, faster than sales. Pet’s new leadership, digital marketing, TikTok Shops and product development are now receiving more resources, while H&G has demonstrated that successful launches can earn broader second-year distribution. Those channels have a plausible commercial purpose, but management did not quantify their incremental return.

"We expect investment spend to remain elevated relative to the first half as we reinvest margin gains from our pricing decisions back into the brands in support of long-term growth."
— Faisal Qadir, CFO

Assessment: Spectrum is moving from protecting profit to spending for growth. We assume recurring EBITDA expands more slowly than this quarter’s 27.5% pace because part of the pricing benefit funds that transition. Continued share gains can justify the spending; a prolonged gap between investment growth and volume growth would weaken the self-help pillar.

3. Capital returns remain discretionary

Repurchases rose from $6.8M in Q2 to $15.8M in Q3, but remained modest relative to the authorization. The $258.9M cash balance also reflects the arrival of outside HPC financing, rather than operating cash generation alone. Spectrum has capacity to act, but preserving liquidity for acquisitions and commercial investment competes with accelerated repurchases.

"We will continue to be opportunistic in share repurchases to ensure flexibility as we look to capitalize on market opportunities and dislocations."
— David Maura, Chairman & CEO

Assessment: The balance-sheet pillar remains strong, even after removing the refund from the leverage denominator. Authorization is useful optionality, not a forecast of share-count reduction. We hold the valuation share denominator at 23.1M and assume the current $0.47 quarterly dividend continues; acquisitions or larger repurchases would require a new capital-allocation assessment.

4. Oaktree finances a platform, while the exit remains open

The partnership has moved from announcement to funding. Spectrum retains control and continues consolidating HPC; the June balance sheet includes a $60M HPC term loan and $61.8M of redeemable noncontrolling interest. An additional $5.8M preferred investment closed on July 8, taking Oaktree’s as-converted ownership from 24.9% to 27.3%. The preferred claim earns an 8% annual accretion, compounded quarterly, and its liquidation allocation is the higher of that accretion or its as-converted share of comprehensive income. The $104M impairment associated with the transaction is noncash, but it cautions against treating the financing as proof that HPC’s historical carrying values were recoverable.

"But in terms of M&A, we're wide open right now, and we're looking at a bunch of stuff."
— David Maura, Chairman & CEO

Assessment: The strategic pillar has advanced operationally, but there is no announced full sale, proceeds target or completion date. We value the consolidated business and deduct the outside HPC claim as well as net debt. A successful combination could create value, but giving Spectrum credit for all consolidated earnings and all equity proceeds would overstate what belongs to common shareholders.

5. ERP completion removes an execution burden before adding savings

July deployments put all of GPC and H&G, plus HPC North America, onto S/4HANA. HPC EMEA remains scheduled for later in calendar 2026. The transition has already affected order timing, making completion relevant both to reported growth and operating reliability.

"The real opportunity for our company lies in what comes next, leveraging this new platform to further standardize our processes, drive efficiency improvements and ultimately unlock the full potential of what a unified global ERP system can deliver for our business and our stakeholders."
— David Maura, Chairman & CEO

Assessment: Above-95% fill rates suggest Spectrum is managing the change without sacrificing service. Completion should reduce implementation disruption, but the value from standardized processes still has to be earned. Our modest FY27 profit growth allows normal productivity improvement; it includes no separate, undisclosed ERP savings windfall.

6. FY27 visibility has not caught up with the recovery

The FY26 outlook is firmer, but management is only beginning the FY27 planning process. Garden demand remains weather sensitive, pet’s improved assortment must sustain share gains, and next year’s inflation has not been quantified. Successful tariff mitigation to date is evidence of capability, rather than a guarantee that future costs will be offset without demand consequences.

"I don't think I can with confidence tell you what '27 inflation looks like."
— Faisal Qadir, CFO

Assessment: This is a reasonable limit on visibility rather than a guide cut. It also means the next increase in fair value must come from a supported FY27 earnings plan or a concrete transaction. We forecast 4.9% underlying EBITDA growth in FY27, with commercial gains partly absorbed by spending, instead of extending Q3’s growth rate.

Guidance & Outlook

Implied finish: FY25 sales were $2,809.0M and adjusted EBITDA was $289.1M. Our $2,849M sales estimate, up 1.4%, requires $709.8M in Q4 after $2,139.2M through June, versus $733.5M last year. Our $305M underlying EBITDA estimate, up 5.5%, requires $60.7M in Q4 after $244.3M year to date, versus $63.4M last year. That is a 3.2% sales decline and 4.3% EBITDA decline, consistent with garden inventory payback, tougher pet comparisons and elevated investment.

A 4–6% analyst interpretation of mid-single-digit EBITDA growth corresponds to approximately $301–306M for the year and $56–62M in Q4. This range is our translation of qualitative guidance. It shows why the raise can coexist with a softer finish: the nine-month operating improvement has already done much of the work.

Cash outlook: Applying 50% conversion to $305M implies about $152.5M of full-year adjusted FCF before tariff refunds. Roughly $133M was already generated on that basis through June, leaving about $19M for Q4. Higher planned capex and reinvestment help explain the limited incremental cash requirement. Refund collections add liquidity separately, while their P&L benefit remains excluded from this recurring framework.

Analyst Q&A Highlights

Price and volume: where the growth comes from

The opening exchange tested whether growth came only from pricing and asked how innovation was contributing. Management gave product examples rather than a companywide vitality index; the CFO separately confirmed that both price and volume were positive in pet and garden.

Q: "Can you talk a little bit about the kind of price volume dynamic that you had and how much the timing of pricing, how much more that will benefit you right now?"
— Bob Labick, CJS Securities

A: "But as I look forward to the year, I think for the full year, we will end up having both positive volume growth and pricing growth in GPC and H&G businesses. our HPC business will remain challenged on volume."
— Faisal Qadir, CFO

Assessment: The answer supports a more durable recovery than pricing alone would deliver, while preserving the distinction between stronger pet/garden and weak HPC volumes. This refers to FY26; it is not a quantitative FY27 growth promise.

Garden inventory: the quality of the year-end handoff

The most consequential challenge focused on whether the record quarter would leave the channel healthy entering FY27. Management linked excess inventory to April replenishment followed by softer consumption and said its framework aims to restore a healthy year-end position.

Q: "Can you give us a sense of, number one, just what did that volatility look like intra-quarter? And more importantly, can you frame the inventory levels that you're looking at going into fiscal Q4? I mean most of this is really about understanding your potential to end the year with healthy inventory levels as you go into fiscal '27?"
— Christopher Carey, Wells Fargo Securities

A: "But the retailers ordered and took inventory based on a very strong April. So, a lot of our retailer partners now have inventory positions higher there than what they would expect because of the softer POS in May and June and then continued softer POS in July. So that's why we're a little bit more guarded in where I think our Q4 goes for Home & Garden. […] We would like to end the year at a good healthy inventory level, and our projections right now kind of are tracking to that. That's kind of what we're embedding in our framework right now as we talk about it."
— Faisal Qadir, CFO

Assessment: The causal explanation is credible, but it does not quantify the excess or prove clearance by September. Our Q4 decline absorbs replenishment pressure; carryover into the next selling season would be a more serious setback than the expected near-term slowdown.

Refund collection: earnings are booked before cash arrives

The refund exchange clarified that additional collection should largely convert a receivable into cash, rather than generate another round of earnings. Management expected most collections within the fiscal year and the remainder by calendar year-end.

Q: "On the tariff refund front, can you just clarify a little bit on -- is there a way to quantify a bit more detail how much cash has been received to date associated with the refunds contemplated? And then as you look ahead, just any kind of magnitude on any additional earnings potential and subsequent cash benefit of refunds still in process?"
— Stephen Robert Powers, Deutsche Bank

A: "Yes. Look, at the end of the quarter, we had actually booked all of our refunds, but received very little in cash. I can tell you since then, and our refund is kind of 2 phases, Phase 1 and Phase 2, and it was filed at different timing. all of which was booked on our P&L in the third quarter. At this point, we've received -- sitting here today, I can tell you we've received all of the Phase 1, and we've started to receive Phase 2. So, the total impact, I expect most of it will be received within the year by -- within the fiscal year. And definitely, by the end of the calendar year, we'll receive all of the cash. But I'd say about half of it is already in, and I expect most of it to still hit the fiscal year from a cash perspective."
— Faisal Qadir, CFO

Assessment: This resolves part of the prior refund uncertainty and supports near-term liquidity. The investment consequence is a lower funding requirement, not a second earnings catalyst of the same size.

HPC alternatives: no prerequisite, but no transaction commitment

The strategic question asked whether operating or financial milestones stood between HPC and a transaction. Management said there was no required hurdle, then emphasized organic commercial development and consolidation possibilities.

Q: "And then, David, on HPC and the strategic alternatives that are being contemplated, I guess, as you work through it, are there specific operational or financial milestones that you need to clear before those alternatives become more actionable? I guess just how you're viewing that contemplated path over the next series of months and quarters?"
— Stephen Robert Powers, Deutsche Bank

A: "No, there's nothing we need to clear. I mean at the end of the day, what you can control is your organic growth. And so that's always priority one. […] But at the end of the day, I think we have tremendous opportunity organically on those commercial levers that we talked about for the other businesses, which is we've got some decent innovation. How do we get some better storytelling? How do we become more relevant? How do we crank up share of voice on digital and really target younger consumers? So that's kind of some of what the growth pillars will be as we roll them out internally organically. But in terms of M&A, we're wide open right now, and we're looking at a bunch of stuff. And we think with the lowest levered balance sheet and an amazing partner that we have in Oaktree, we should be the consolidation platform of choice, and we think there's a lot of money to be made in the space. And as we see the relationship mature with Oaktree, we hope to share that detail with you. But we're wide open."
— David Maura, Chairman & CEO

Assessment: Financing gives management room to pursue a transaction while improving the business. The answer offers no schedule that would make an exit a dependable 12-month catalyst, so our base valuation continues to reflect ownership of a consolidated appliance operation.

FY27 cost and demand confidence: capability without a budget

The final-year outlook discussion tested whether apparent confidence rested on next year’s shelf plans or a quantified inflation view. Management pointed to brand performance and its pipeline, while acknowledging that retailer plans and weather remain too early to assess.

Q: "And just as we go into fiscal '27, I think you mentioned confidence in growing top line volume and pricing and in Pet and Garden, correct me if I heard that wrong. What embeds that confidence? Is that early plans that you have, early discussions on shelf space going into next year?"
— Christopher Carey, Wells Fargo Securities

A: "Yes. So, look, it's really early to talk about next year outside of just our product portfolio, our pipeline and our brand performance. And the basis for my confidence comes from all of those things. This is a very weather-dependent business. We don't know what the weather is like. It's actually even too early to even know what the retailers' outlook would be like for next year. But all the things that are in our control are pointing in the right direction, and that's what gives us confidence."
— Faisal Qadir, CFO

Assessment: Product and brand progress justify a moderate analyst growth assumption. They do not establish a committed FY27 sales trajectory. This distinction matters at a share price that already discounts continued recovery.

What They’re NOT Saying

1. How much garden inventory must clear: There is no channel inventory dollar amount or weeks-of-supply measure. The missing scale makes it difficult to distinguish a Q4 replenishment pause from inventory that could weigh on the next season.
2. The return on higher commercial spending: Successful trap launches demonstrate a mechanism, but there is no portfolio-wide innovation contribution or incremental marketing return. Sustained volume and share gains must carry that proof.
3. A complete HPC exit plan: No buyer, price, timetable or distribution to Spectrum holders was announced. The earlier $60M-plus EBITDA aspiration remains a watch item rather than a newly quantified exit valuation.
4. A numerical FY27 framework: Management has not yet set sales, EBITDA or inflation assumptions. The current EBITDA raise reflects FY26 performance and should not be read as next-year guidance.

Market Reaction

• Pre-print setup: SPB closed August 6 at $88.26, up 49.4% YTD, 55.2% over 12 months and 8.1% over 30 days. The pre-print 52-week closing range was $50.35–90.97; the S&P 500 was up 12.6% YTD.
• August 7 reaction session: Shares opened at $96.50, a 9.3% gap, traded between $88.02 and $99.06, and closed at $90.13, up 2.1% or $1.87. Volume was about 0.8M shares, 2.3 times the 30-day average. The S&P 500 rose 0.6%.

The stock retained a gain but surrendered most of its opening advance. Our interpretation is that the initial appeal of a broad sales beat, refund recognition and another EBITDA raise met a more demanding question on the call: how much recurring growth remains after garden replenishment slows and investment rises? The session cannot isolate those causes, but its path is consistent with a market unwilling to capitalize the headline EPS at face value.

This is a different setup from May’s post-print pullback. The current price sits within the prior $88–100 fair-value range, and the operating improvement has been accompanied by a substantial further rise in the stock. The remaining return depends increasingly on FY27 execution or a value-creating transaction. A successful Q3 alone no longer supplies the valuation cushion behind our earlier Outperform.

Street Perspective

Debate: operating recovery or refund-assisted earnings optics?

Bull view: All three businesses grew and expanded margins excluding refunds, validating cost actions and stronger brands. A further increase in the EBITDA framework makes the recovery more credible.

Bear view: The outsized EPS beat is mostly a tariff recovery, and ex-refund EPS fell. Higher investment and taxes limit the translation of gross-profit gains into common-share earnings.

Our take: The bull has the better operating argument, because $97.7M of underlying EBITDA is real progress. The bear has the stronger objection to the headline valuation shortcut. We raise recurring EBITDA modestly while judging returns on normalized earnings and cash.

Debate: garden innovation versus channel inventory payback

Bull view: New products, wider distribution and share gains helped produce a record quarter despite an uneven season. A softer Q4 could simply restore healthier retailer stocks.

Bear view: April sell-in ran ahead of later consumption; the record may borrow orders from the next quarter. Persistent heat could make clearance slower than expected.

Our take: Both mechanisms are visible. We expect a Q4 decline without abandoning the full-year growth case. The critical next disclosure is whether retail inventory exits the season normally; unresolved excess would lower our FY27 outlook.

Debate: funded strategic options versus a prolonged conglomerate discount

Bull view: Oaktree funding, lower net debt and refund cash create capacity to build or separate HPC while expanding pet and garden.

Bear view: HPC remains consolidated, has weaker margins and now has an outside economic claim. Deploying cash into acquisitions can delay its return to shareholders and introduce execution risk.

Our take: The strategic option has improved, but its timing is still too uncertain to close the valuation case. Our base includes moderate organic improvement and a minority-interest deduction. A concrete, accretive transaction could support renewed Outperform conviction.

Model Update & Valuation

Our FY26 sales build assumes Q4 pet revenue of about $287M, H&G of $129M and HPC of $293.8M. Relative to FY25 Q4, these represent declines of 3.7%, 7.3% and 0.8%, respectively. These assumptions incorporate the disclosed shipment comparisons and garden inventory risk while allowing HPC’s rate of decline to moderate. They are analyst forecasts, not additional company guidance.

The FY26 EPS estimate starts with the filed nine-month adjusted $5.41 less the disclosed $1.90 refund contribution, giving $3.51. For Q4, $60.7M EBITDA less $32.5M of depreciation, amortization and share compensation and $8M of net financing/other expense, taxed at 32.8% over 23.1M shares, produces about $0.59. That yields approximately $4.10 excluding refunds, or $6.00 including the already recognized refund. The annual tax assumption and continuing investment constrain EPS even as recurring EBITDA rises.

Our initial FY27 EBITDA estimate adds $15M to FY26: approximately $9M from GPC distribution and mix, $4M from H&G product reach and a normalized channel, and $5M from HPC productivity and commercial improvement, less $3M of higher corporate expense. These are explicit analyst assumptions. They require no acquisition, full HPC sale, fresh tariff refund or repeat of the record Q3 growth rate.

An explicit 12-month enterprise-to-equity bridge

The base calculation is ($320M × 8.0 − $300M − $90M) ÷ 23.1M = $93.9 per share. The 8.0x multiple is our valuation judgment for a modest-growth, mixed-margin portfolio with strong funding capacity and an unfinished separation. It does not assume convergence to a premium staples multiple. The prior report did not specify a target multiple; today’s explicit bridge replaces that broad comparison while keeping fair value close to its prior range.

We reserve $90M for the outside HPC interest, above the June carrying amount and subsequent preferred issuance. This is consistent with an illustrative $65M HPC EBITDA valuation at 6.0x, less its $60M term loan, multiplied by Oaktree’s 27.3% interest. It also exceeds an approximate $75M preferred principal-and-accretion reference at the valuation horizon. This is an analyst allocation assumption; actual preferred rights and transaction proceeds can change the claim’s fair value. A $30M higher claim lowers common value by about $1.30 per share. Consolidated net debt already includes the HPC term loan, so that loan is not deducted twice. No full-sale proceeds or incremental refund earnings are added to the bridge.

The base $300M net-debt assumption allows a $74.1M improvement from June. From the June balance sheet through our August 2027 valuation date, approximately $160M of assumed underlying FCF plus $57.9M of remaining June refund receivables and the July $5.8M preferred issuance supplies funding; roughly $50M of ordinary dividends and about $100M of repurchases, reinvestment, taxes and other cash uses absorb the balance. These are allocation assumptions rather than commitments. Holding the share denominator constant gives no separate per-share benefit for assumed repurchases. In the downside, weaker garden demand and commercial returns leave EBITDA below FY26 and net debt near June’s level; the upside requires stronger distribution gains and more cash retention.

Rating consequence: Approximately 6.3% base total return is broadly in line with our explicit 8% S&P 500 return hurdle over the same 12 months. The roughly 14% downside case and unfinished FY27 earnings plan leave insufficient excess return for Outperform. Hold recognizes the operating recovery while awaiting either a better entry, evidence that the channel exits cleanly with stronger FY27 earnings, or a transaction that adds value after outside claims.

Thesis Scorecard Post-Earnings

Overall: The durable operating case strengthened, but its return advantage narrowed. Pet growth survived the known reversal, H&G fulfilled the peak-season test, and the EBITDA framework rose. The prior downgrade conditions were not triggered by a failed Q3 pet or garden print; the change in rating follows the fuller valuation and newly visible channel pressure. Refund optionality has partly crystallized and HPC funding has advanced, without creating an immediate recurring earnings stream or clean exit.

Commitments to watch: Delivery of the raised FY26 EBITDA framework and roughly 50% ex-refund FCF conversion; garden retailer inventory normalization; pet share and consumption through the difficult Q4 comparison; HPC full-year profit improvement against the earlier $60M-plus aspiration and any concrete separation terms; allocation of the remaining buyback authorization versus M&A; refund collection by fiscal/calendar year-end; and completion of the remaining HPC EMEA ERP deployment later in 2026.

Action: Downgrade to Hold, conviction 6. A clean channel exit plus a FY27 plan exceeding our $320M recurring EBITDA base, or an accretive HPC transaction, could restore expected outperformance. Carryover inventory that undermines next season, a cut to recurring guidance, or cash deployment that erodes the balance-sheet advantage would weaken the case further.